{"id":48649,"date":"2022-09-21T15:01:40","date_gmt":"2022-09-21T13:01:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/"},"modified":"2022-09-21T15:01:40","modified_gmt":"2022-09-21T13:01:40","slug":"insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/","title":{"rendered":"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 &#8211; Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5646408\/opioid-induced-constipation-drugs-market-size?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=z8f7lw&amp;utm_campaign=1752795+-+Insights+on+the+Opioid+Induced+Constipation+Drugs+Global+Market+to+2030+-+Featuring+AstraZeneca%2C+Daiichi+Sankyo%2C+Pfizer+and+Salix+Pharmaceuticals+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Opioid Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220921005680\/en\/1578940\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220921005680\/en\/1578940\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global opioid induced constipation drugs market is rising at a significant pace, projected to rise at a CAGR of 4.7% during the estimated period from 2022 to 2030.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAstraZeneca plc\n<\/li>\n<li>\nCubist Pharmaceuticals (Adolor Corporation)\n<\/li>\n<li>\nDaiichi Sankyo Co. Ltd.\n<\/li>\n<li>\nIronwood Pharmaceuticals Inc.\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nProgenics Pharmaceuticals Inc.\n<\/li>\n<li>\nSalix Pharmaceuticals Ltd.\n<\/li>\n<li>\nShionogo &amp; Co. Ltd.\n<\/li>\n<li>\nSucampo Pharmaceuticals Inc.\n<\/li>\n<li>\nSynergy Pharmaceuticals Inc\n<\/li>\n<\/ul>\n<p>\nThe mechanism of action of opioid analgesics through binding to the mu, delta, and kappa receptors present in the brain by crossing the blood-brain barrier and giving the desired analgesic effect to treat non-cancer pain. In addition, the opioids bind to the mu receptors present in the gastrointestinal tract, which result in a contraction of the smooth muscles and alter the peristaltic movement causing constipation.\n<\/p>\n<p>\nUsually, the patients opt for over the counter osmotic laxatives and stimulant cathartics, which have been beneficial in providing relief from constipation in patients taking opioid analgesics for 3-4 weeks. In patients seeking palliative care, doctors prescribe mu-receptor antagonists and prostaglandin derivatives to cure opioid induced constipation.\n<\/p>\n<p>\nIn the present scenario, prescribed drugs are dominating the market on account of an increasing number of patients showing resistance to over-the-counter laxatives and cathartics. Moreover, opioid analgesics binds to the mu receptors of the gastrointestinal tract causing severe contraction of smooth muscles, altering the peristaltic activity of the gut motility, thus leading to chronic constipation.\n<\/p>\n<p>\nPhysicians usually prescribe branded drugs such as methylnaltrexone bromide and naloxegol (mu-receptor antagonists) and prostaglandin derivatives such as lubiprostone to gain immediate relief from constipation by increasing fluid retention and stool softening. Over the counter (OTC) osmotic laxatives and stimulant cathartics are the drugs of the first choice by the patients to treat constipation. OTC products have shown good results in patients taking opioid analgesics for less than 4 weeks.\n<\/p>\n<p>\nIn addition, lockdown restrictions and the need to maintain social distancing due to the ongoing COVID-19 pandemic have resulted in more number of people staying at home. Hence, a sedentary lifestyle has resulted in the development of opioid induced constipation. In addition, irrational intake of OTC drugs and lack of physical activity will further aggravate the occurrence of opioid induced constipation in the elderly population\n<\/p>\n<p>\n<strong>Key questions answered in this report<\/strong>\n<\/p>\n<ul>\n<li>\nWhat are the key micro and macro environmental factors that are impacting the growth of Opioid Induced Constipation Drugs market?\n<\/li>\n<li>\nWhat are the key investment pockets with respect to product segments and geographies currently and during the forecast period?\n<\/li>\n<li>\nEstimated forecast and market projections up to 2030.\n<\/li>\n<li>\nWhich segment accounts for the fastest CAGR during the forecast period?\n<\/li>\n<li>\nWhich market segment holds a larger market share and why?\n<\/li>\n<li>\nAre low and middle-income economies investing in the Opioid Induced Constipation Drugs market?\n<\/li>\n<li>\nWhich is the largest regional market for Opioid Induced Constipation Drugs market?\n<\/li>\n<li>\nWhat are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East &#8211; Africa?\n<\/li>\n<li>\nWhich are the key trends driving Opioid Induced Constipation Drugs market growth?\n<\/li>\n<li>\nWho are the key competitors and what are their key strategies to enhance their market presence in the Opioid Induced Constipation Drugs market worldwide?\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Preface<\/strong>\n<\/p>\n<p>\n<strong>2. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>3. Opioid Induced Constipation Drugs Market: Business Outlook &amp; Market Dynamics<\/strong>\n<\/p>\n<p>\n3.1. Introduction\n<\/p>\n<p>\n3.2. Global Opioid Induced Constipation Drugs Market Value, 2020 &#8211; 2030, (US$ Million)\n<\/p>\n<p>\n3.3. Market Dynamics\n<\/p>\n<p>\n3.3.1. Market Drivers\n<\/p>\n<p>\n3.3.2. Market Restraints\n<\/p>\n<p>\n3.3.3. Key Challenges\n<\/p>\n<p>\n3.3.4. Key Opportunities\n<\/p>\n<p>\n3.4. Impact Analysis of Drivers and Restraints\n<\/p>\n<p>\n3.5. See-Saw Analysis\n<\/p>\n<p>\n3.6. Porter&#8217;s Five Force Model\n<\/p>\n<p>\n3.7. PESTEL Analysis\n<\/p>\n<p>\n3.8. Heptalysis Analysis\n<\/p>\n<p>\n3.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis &amp; Relevant Solutions\n<\/p>\n<p>\n<strong>4. Opioid Induced Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)<\/strong>\n<\/p>\n<p>\n<strong>5. Opioid Induced Constipation Drugs Market: By Prescription Type, 2020-2030, USD (Million)<\/strong>\n<\/p>\n<p>\n<strong>6. North America Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)<\/strong>\n<\/p>\n<p>\n<strong>7. UK and European Union Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)<\/strong>\n<\/p>\n<p>\n<strong>8. Asia Pacific Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)<\/strong>\n<\/p>\n<p>\n<strong>9. Latin America Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)<\/strong>\n<\/p>\n<p>\n<strong>10. Middle East and Africa Opioid Induced Constipation Drugs Market, 2020-2030, USD (Million)<\/strong>\n<\/p>\n<p>\n<strong>11. Company Profile<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5646408\/opioid-induced-constipation-drugs-market-size?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=z8f7lw&amp;utm_campaign=1752795+-+Insights+on+the+Opioid+Induced+Constipation+Drugs+Global+Market+to+2030+-+Featuring+AstraZeneca%2C+Daiichi+Sankyo%2C+Pfizer+and+Salix+Pharmaceuticals+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/d47axg<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x70;r&#101;&#x73;s&#64;&#x72;&#101;&#x73;&#x65;&#97;&#x72;&#x63;&#104;&#x61;n&#100;&#x6d;a&#114;&#x6b;e&#116;&#x73;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">pr&#101;&#115;&#115;&#64;&#x72;&#x65;&#x73;&#x65;&#x61;rc&#104;&#97;&#110;&#100;&#x6d;&#x61;&#x72;&#x6b;&#x65;ts&#46;&#99;&#111;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Opioid Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global opioid induced constipation drugs market is rising at a significant pace, projected to rise at a CAGR of 4.7% during the &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48649","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Insights on the Opioid Induced Constipation Drugs Global Market to 2030 - Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 - Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Opioid Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global opioid induced constipation drugs market is rising at a significant pace, projected to rise at a CAGR of 4.7% during the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-21T13:01:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220921005680\/en\/1578940\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 &#8211; Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-21T13:01:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/\"},\"wordCount\":773,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005680\\\/en\\\/1578940\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/\",\"name\":\"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 - Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005680\\\/en\\\/1578940\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-21T13:01:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005680\\\/en\\\/1578940\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220921005680\\\/en\\\/1578940\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 &#8211; Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 - Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 - Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Opioid Induced Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global opioid induced constipation drugs market is rising at a significant pace, projected to rise at a CAGR of 4.7% during the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-21T13:01:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220921005680\/en\/1578940\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 &#8211; Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-09-21T13:01:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/"},"wordCount":773,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220921005680\/en\/1578940\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/","name":"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 - Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220921005680\/en\/1578940\/21\/logo.jpg","datePublished":"2022-09-21T13:01:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220921005680\/en\/1578940\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220921005680\/en\/1578940\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/insights-on-the-opioid-induced-constipation-drugs-global-market-to-2030-featuring-astrazeneca-daiichi-sankyo-pfizer-and-salix-pharmaceuticals-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Insights on the Opioid Induced Constipation Drugs Global Market to 2030 &#8211; Featuring AstraZeneca, Daiichi Sankyo, Pfizer and Salix Pharmaceuticals Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48649"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48649\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}